Saskatoon, Canada Clinical Trials

A listing of Saskatoon, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 9 clinical trials
Featured trial
Caregiver-Provided Life Review for Persons with Dementia

This study, Caregiver-Provided Life Review (C-PLR) is created based on Life Review therapy. It is for persons living with early-stage dementia along with mild depressive symptoms who are 65 years or older, community-dwellers or the residents of senior housing, independent or assisted living facilities conducted by their family members (18 …

Accepts healthy volunteers
Online studies
Online Study Center
(online study) Contact site
  • 09 Aug, 2022
  • 1 location
  • Online study
Featured trial
Integument-PED study

We are currently recruiting pediatric and adult patients with mild to moderate atopic dermatitis (eczema) for a study that investigates the safety and efficacy of the ARQ-151 cream. 

Skinsense Medical Research
 (0.4 away) Contact site
  • 17 Aug, 2022
  • +88 other locations
A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma

This study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of intravenous mosunetuzumab in combination with polatuzumab vedotin in participants with diffuse large B-cell lymphoma (DLBCL), and in participants with follicular lymphoma (FL). It will consist of a dose finding portion followed by an expansion phase for second line or …

follicular lymphoma
hodgkin's disease
diffuse large b-cell lymphoma
polatuzumab vedotin
Saskatchewan Cancer Agency (SCA) - Saskatoon Cancer Centre (SCC)
 (1.2 away) Contact site
  • 11 Aug, 2022
  • +28 other locations
A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) (COURAGE-ALS)

The purpose of this study is to assess the effect of reldesemtiv versus placebo on functional outcomes in ALS.

primary lateral sclerosis
Saskatoon City Hospital
 (0.8 away) Contact site
  • 11 Aug, 2022
  • +54 other locations
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis (SELECT-GCA)

This study consists of two periods. The objective of Period 1 is to evaluate the efficacy of upadacitinib in combination with a 26-week corticosteroid (CS) taper regimen compared to placebo in combination with a 52-week CS taper regimen, as measured by the proportion of participants in sustained remission at Week …

Rheumatology Associates /ID# 201843
 (0.2 away) Contact site
  • 09 Aug, 2022
  • +122 other locations
PERC Health Canada COVID-19

Although there are several licensed vaccines for SAR-CoV-2 (COVID-19) in Canada, none of them are approved for use in children under the age of 12, leaving five million children under 12 years unvaccinated. There is a need to find methods of mass rapid point of care testing in unvaccinated populations …

Jim Pattison Children's Hospital
 (1.1 away) Contact site
  • 08 Aug, 2022
  • +12 other locations
Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

The purpose of this study is to compare the efficacy and safety of intravenous (IV) infusions of MT-3921 to placebo in subjects with acute traumatic cervical spinal cord injury. Subjects meeting eligibility criteria will enter the 6-month double-blind period. Subjects will be randomized in a 2:1 ratio to receive MT-3921 …

spinal cord disorder
cervical spinal cord injury
body mass index
spinal cord
University of Saskatchewan
 (1.1 away) Contact site
  • 09 Aug, 2022
  • +46 other locations
A Study to Assess the Change in Disease State in Adult Participants Being Treated With Oral Upadacitinib Tablets in Participants With Oligo- or Poly-artIcular Psoriatic Arthritis (UPJOINT)

Psoriatic arthritis (PsA) is a type of arthritis (swelling and stiffness in the joints) that is frequently seen in trial participants who also have the skin condition psoriasis. It is caused by the body's immune system mistakenly attacking healthy joint tissue causing inflammation, joint damage, disability, and a reduced life …

Dr. Latha Naik /ID# 234149
 (0.7 away) Contact site
  • 08 Aug, 2022
  • +89 other locations
Canadian Real-life Post-marketing Observational Study Assessing the Effectiveness of Upadacitinib for Treating Rheumatoid Arthritis (CLOSEUP) (CLOSEUP)

Rheumatoid Arthritis (RA) is an inflammatory disease of the joints causing pain, stiffness, swelling and loss of joint function. This study will assess how effective Upadacitinib is in changing the disease symptoms in Canadian participants with RA. Upadacitinib is a drug approved for the treatment of moderately to severely active …

Rheumatology Associates /ID# 228584
 (0.2 away) Contact site
  • 20 Aug, 2022
  • +32 other locations